Статті в журналах з теми "Pharmaceutical fraud"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Pharmaceutical fraud".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Lu, Zhiqiang, Zaina Parvez Qureshi, Brian Chen, Sudha Xirasagar, Paul Ray, Gowtham Rao, Isaac Lopez, et al. "Why Is Cancer Care So Expensive: Potential Implications of Fraud and Abuse." Blood 120, no. 21 (November 16, 2012): 4275. http://dx.doi.org/10.1182/blood.v120.21.4275.4275.
Повний текст джерелаMa, Jianwei, Na Wang, and Qiangzu Li. "The Failure of Kangmei, the Lesson of A-Shares." International Business & Economics Studies 4, no. 2 (May 20, 2022): p88. http://dx.doi.org/10.22158/ibes.v4n2p88.
Повний текст джерелаValverde, José Luis. "Corporate responsibility and pharmaceutical fraud." Pharmaceuticals, Policy and Law 14, no. 2-4 (2012): 129–56. http://dx.doi.org/10.3233/ppl-120350.
Повний текст джерелаHoeksema, HL, J. Troost, DE Grobbee, WM Wiersinga, FCB van Wijmen, and EC Klasen. "Fraud in a pharmaceutical trial." Lancet 356, no. 9243 (November 2000): 1773. http://dx.doi.org/10.1016/s0140-6736(05)71970-x.
Повний текст джерелаLiu, Siyang. "The Impact of Chinas Independent Director System on Corporate Financial Fraud: The Case of Kangmei Pharmaceutical Fraud." Advances in Economics, Management and Political Sciences 4, no. 1 (March 21, 2023): 621–28. http://dx.doi.org/10.54254/2754-1169/4/2022980.
Повний текст джерелаCodaste, Harold L., Charlnette Mae T. Lasiste, and Alexander Franco A. Delantar. "Preliminary Fraud Risk Assessment of a Pharmaceutical Distributor." International Journal on Graft and Corruption 2, no. 1 (January 23, 2015): 11–23. http://dx.doi.org/10.7719/ijgc.v2i1.299.
Повний текст джерелаChen, Yaling, Shan Xiong, and Ting Duan. "A Case Study of Fraud in Xinjiang Ready Health Industry Co.,Ltd. Based on Fraud Triangle Theory." Frontiers in Business, Economics and Management 8, no. 2 (April 6, 2023): 134–38. http://dx.doi.org/10.54097/fbem.v8i2.7127.
Повний текст джерелаWhite, Jeb. "Masterminds behind pharmaceutical fraud deserve prison time." Nature Medicine 16, no. 9 (September 2010): 956. http://dx.doi.org/10.1038/nm0910-956.
Повний текст джерела., Olivia. "PENGARUH PENGENDALIAN.INTERNAL, INDEPENDENSI, WHISTLEBLOWING SYSTEM, ANTI-FRAUD AWARENESS, DAN INTEGRITAS TERHADAP PENCEGAHAN FRAUD." Jurnal Ekonomi Trisakti 2, no. 2 (August 10, 2022): 261–72. http://dx.doi.org/10.25105/jet.v2i2.14217.
Повний текст джерелаDai, Liqin. "Identification of Financial Fraud in Listed Companies and Analysis of Preventive Measures - A Case Study of Kangmei Pharmaceutical." BCP Business & Management 27 (September 6, 2022): 350–62. http://dx.doi.org/10.54691/bcpbm.v27i.1982.
Повний текст джерелаAkomea-Frimpong, Isaac, and Charles Andoh. "Understanding and controlling financial fraud in the drug industry." Journal of Financial Crime 27, no. 2 (January 31, 2020): 337–54. http://dx.doi.org/10.1108/jfc-06-2019-0071.
Повний текст джерелаSetiyowati, Supami Wahyu, Mochamad Fariz Irianto, and Irma Tyasari. "Determinan Pencegahan Kecurangan Pengelolaan Dana Desa Dimoderasi Kompetensi Aparatur." Organum: Jurnal Saintifik Manajemen dan Akuntansi 5, no. 1 (June 30, 2022): 62–72. http://dx.doi.org/10.35138/organum.v5i1.197.
Повний текст джерелаKevorkova, Z. A., and I. A. Zhukova. "HIGH RISK AREAS OF FRAUD ON PHARMACEUTICAL MARKET." Современная экономика проблемы и решения, no. 2 (2023): 81–90. http://dx.doi.org/10.17308/meps/2078-9017/2023/2/81-90.
Повний текст джерелаLi, Yanan. "Identification and Audit Response of Financial Fraud in Listed Companies in Pharmaceutical Industry." Frontiers in Business, Economics and Management 7, no. 2 (February 5, 2023): 15–19. http://dx.doi.org/10.54097/fbem.v7i2.4353.
Повний текст джерелаKesselheim, Aaron S., David M. Studdert, and Michelle M. Mello. "Whistle-Blowers' Experiences in Fraud Litigation against Pharmaceutical Companies." New England Journal of Medicine 362, no. 19 (May 13, 2010): 1832–39. http://dx.doi.org/10.1056/nejmsr0912039.
Повний текст джерелаPeltier-Rivest, Dominic, and Carl Pacini. "Detecting counterfeit pharmaceutical drugs." Journal of Financial Crime 26, no. 4 (October 7, 2019): 1027–47. http://dx.doi.org/10.1108/jfc-06-2018-0057.
Повний текст джерелаShalaby, Azza Helmy Mahmoud, and Ahmad Abdulkareem Mohammad Al-Harkan. "The awareness of judicial accounting techniques towards the expectations of the external auditor in detecting fraud and its impact on the performance." Accounting 8, no. 3 (2022): 345–54. http://dx.doi.org/10.5267/j.ac.2021.10.003.
Повний текст джерелаQureshi, Zaina P. "Pharmaceutical Fraud and Abuse in the United States, 1996-2010." Archives of Internal Medicine 171, no. 16 (September 12, 2011): 1503. http://dx.doi.org/10.1001/archinternmed.2011.397.
Повний текст джерелаDewi, Nurul Hasanah Uswati, Putri Wulanditya, Dian Oktarina, and Herwin Ardianto. "Banking sector lack detection: Expectation gap between auditors and bankers." Accounting 7, no. 6 (2021): 1353–62. http://dx.doi.org/10.5267/j.ac.2021.4.002.
Повний текст джерелаAnas, Dadio Fiasani, and Anastasia Filiana Ismawati. "EFFECT FRAUD DIAMOND THEORY DETECTING FINANCIAL STATEMENT FRAUD WITH PANDEMIC AS CONTROL VARIABLE." JOURNAL OF ACCOUNTING, ENTREPRENEURSHIP AND FINANCIAL TECHNOLOGY (JAEF) 4, no. 1 (October 28, 2022): 15–28. http://dx.doi.org/10.37715/jaef.v4i1.2754.
Повний текст джерелаToothman, Myranda, Ken Moore, and Doohee Lee. "Unraveling Medicare and Medicaid Prescription Drug Fraud and Abuse." Compensation & Benefits Review 43, no. 6 (April 13, 2011): 339–45. http://dx.doi.org/10.1177/0886368711405018.
Повний текст джерелаAriyanto, Dodik, I. Made Gilang Jhuniantara, Ni Made Dwi Ratnadi, I. Gusti Ayu Made Asri Dwija Putri, and Ayu Aryista Dewi. "Detecting fraudulent financial statements in pharmaceutical companies: Fraud pentagon theory perspective." Accounting 7, no. 7 (2021): 1611–20. http://dx.doi.org/10.5267/j.ac.2021.5.009.
Повний текст джерелаBurrell, Darrell Norman, Sharon L. Burton, Delores Springs, Jorja B. Wright, Maurice D. Harmon, and Eugene J. M. Lewis. "A Qualitative Research Assessment of the MBA for 2020 and Beyond." International Journal of Smart Education and Urban Society 11, no. 3 (July 2020): 23–41. http://dx.doi.org/10.4018/ijseus.2020070103.
Повний текст джерелаHayashi, Merrick Max Dillard. "Pharmaceutical Phonies: The Entanglement of Fraud, Third-Party Payors, and Proximate Cause in Civil RICO Cases." Texas A&M Law Review 9, no. 4 (December 13, 2021): 1–11. http://dx.doi.org/10.37419/lr.v9.arg.1.
Повний текст джерелаBarrientos, Claudio, and Silvana Moris. "Teaching organic nomenclature for pharmacy students: Adapting a course to online mode during COVID-19." Pharmacy Education 22, no. 1 (May 28, 2022): 360–75. http://dx.doi.org/10.46542/pe.2022.221.360375.
Повний текст джерелаRosdini, Dini, Aria Farah Mita, and Dyah Setyaningrum. "Internal auditor reports a fraud: Courage and pressure." Accounting 7, no. 7 (2021): 1813–18. http://dx.doi.org/10.5267/j.ac.2021.6.001.
Повний текст джерелаRein, Frederick H., and Joseph B. Crystal. "Unigene Laboratories, Inc. et al. v. Apotex, Inc. et al.: Reformulating an old drug is not as obvious as one might think." Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 9, no. 1 (March 2012): 36–44. http://dx.doi.org/10.1177/1741134311433733.
Повний текст джерелаWidiastika, Audri, and Junaidi Junaidi. "Fraud Pentagon dalam Mendeteksi Kecurangan Laporan Keuangan." Jurnal Akuntansi, Keuangan, dan Manajemen 3, no. 1 (December 25, 2021): 83–98. http://dx.doi.org/10.35912/jakman.v3i1.747.
Повний текст джерелаGreenman, Zac, and Dr Cindy Greenman, CFE. "Pharmaceutical Fraud: Off-Label Marketing of Drugs in the United States, 2009-2016." Research in Economics and Management 2, no. 5 (October 26, 2017): 198. http://dx.doi.org/10.22158/rem.v2n5p198.
Повний текст джерелаPatria, Harry. "Predicting Fraudulence Transaction under Data Imbalance using Neural Network (Deep Learning)." Data Science: Journal of Computing and Applied Informatics 6, no. 2 (July 31, 2022): 67–80. http://dx.doi.org/10.32734/jocai.v6.i2-8309.
Повний текст джерелаNanda, Satria tri, Neneng Salmiah, and Dina Mulyana. "FRAUDULENT FINANCIAL REPORTING: A PENTAGON FRAUD ANALYSIS." Jurnal Ilmiah Ekonomi Dan Bisnis 16, no. 2 (September 24, 2019): 122–34. http://dx.doi.org/10.31849/jieb.v16i2.2678.
Повний текст джерелаHorowitz, Arthur M. "Fraud and Investigator Integrity in Clinical Research." Clinical Research and Regulatory Affairs 12, no. 2 (January 1995): 131–41. http://dx.doi.org/10.3109/10601339509079583.
Повний текст джерелаHaddab, Daniella Maya. "Detecting banking frauds with analytics and machine learning." Business & IT XIII, no. 1 (2023): 90–96. http://dx.doi.org/10.14311/bit.2023.01.11.
Повний текст джерелаBudiman, Monika, Choirul Anwar, and Sudjono Sudjono. "FACTORS AFFECTING FRAUD PREVENTION AND ITS IMPLICATION TO THE QUALITY OF FINANCIAL STATEMENTS." Journal of Applied Finance & Accounting 8, no. 1 (March 30, 2022): 1–25. http://dx.doi.org/10.21512/jafa.v8i1.6858.
Повний текст джерелаCarder, Elizabeth B., and Joseph W. Metro. "Appendix A. Minefields for the Unwary: Fraud and Abuse Issues Affecting Pharmaceutical Manufacturers." Journal of Pharmaceutical Marketing & Management 12, no. 2-3 (January 1998): 125–44. http://dx.doi.org/10.3109/j058v12n02_13.
Повний текст джерелаQureshi, Z., O. Sartor, and C. Bennett. "PHP3 FEDERAL ENFORCEMENT ACTIONS AGAINST FRAUD AND ABUSE BY PHARMACEUTICAL MANUFACTURERS: 1996-2010." Value in Health 14, no. 3 (May 2011): A12. http://dx.doi.org/10.1016/j.jval.2011.02.077.
Повний текст джерелаRazali, Nur Amira Hidayah, Wan Rosalili Wan Rosli, and Mohd Bahrin Othman. "The Legal Protection of E-Consumers Against E-Commerce Fraud in Malaysia." Malaysian Journal of Social Sciences and Humanities (MJSSH) 7, no. 9 (September 30, 2022): e001778. http://dx.doi.org/10.47405/mjssh.v7i9.1778.
Повний текст джерелаFaunce, Thomas A., Gregor Urbas, and Lesley Skillen. "Implementing US‐style anti‐fraud laws in the Australian pharmaceutical and health care industries." Medical Journal of Australia 194, no. 9 (May 2011): 474–78. http://dx.doi.org/10.5694/j.1326-5377.2011.tb03066.x.
Повний текст джерелаBraillon, Alain. "Implementing US‐style anti‐fraud laws in the Australian pharmaceutical and health care industries." Medical Journal of Australia 195, no. 10 (November 2011): 585. http://dx.doi.org/10.5694/mja11.10601.
Повний текст джерелаKhuluqi, Khusnul, and Napisah. "Pengaruh Fraud Pentagon Terhadap Kecurangan Laporan Keuangan Dengan Ukuran Perusahaan Sebagai Pemoderasi." WACANA EKONOMI (Jurnal Ekonomi, Bisnis dan Akuntansi) 21, no. 2 (November 2, 2022): 198–211. http://dx.doi.org/10.22225/we.21.2.2022.198-211.
Повний текст джерелаVictory, Chika Odukwu, Eke Promise, and Chukwumati N. Mike. "Impact of Cyber-Security on Fraud Prevention in Nigerian Commercial Banks." Jurnal Akuntansi, Keuangan, dan Manajemen 4, no. 1 (December 19, 2022): 15–27. http://dx.doi.org/10.35912/jakman.v4i1.1527.
Повний текст джерелаCheng, Ching Hung, Zhe Huang, Siqi Lin, and Hangyu Wu. "Analysis of Corporation’s Financial Fraud and Independent Directors’ Decision Based on Evolutionary Game Theory." BCP Business & Management 31 (November 5, 2022): 195–204. http://dx.doi.org/10.54691/bcpbm.v31i.2561.
Повний текст джерелаLiu, Mengna, and Jinshi Chen. "A Critical Metaphor Analysis of Anti-telefraud Public Legal Education Discourse." International Journal of Linguistics, Literature and Translation 5, no. 3 (March 13, 2022): 108–13. http://dx.doi.org/10.32996/ijllt.2022.5.3.14.
Повний текст джерелаLlarena, Zharama. "Organized Corporate Crimes using UNCITRAL Arbitration Framework Development for EPC Disclosure concerning Epistemic Corruption and Pharmaceutical Fraud of Off-label Medicines as Health Regulation and Policy." International Journal of Communication and Public Relation 8, no. 1 (February 27, 2023): 40–55. http://dx.doi.org/10.47604/ijcpr.1787.
Повний текст джерелаGabriel, Joseph M., and Bennett Holman. "Clinical trials and the origins of pharmaceutical fraud: Parke, Davis & Company, virtue epistemology, and the history of the fundamental antagonism." History of Science 58, no. 4 (July 25, 2020): 533–58. http://dx.doi.org/10.1177/0073275320942435.
Повний текст джерелаMironova, O. I., L. A. Ruonala, and E. S. Mironov. "Digitalization of Social Contacts – Risks for Women Seeking a Spouse through Dating Sites and Apps." Psychology and Law 11, no. 4 (2021): 42–63. http://dx.doi.org/10.17759/psylaw.2021110404.
Повний текст джерелаSetiyorini, Ika, and Desi Susilawati. "Accounting Information System And Prevention Of Fraudulent Drug Supply At The Kardinah Tegal General Hospital." Proceedings University of Muhammadiyah Yogyakarta Undergraduate Conference 2, no. 1 (June 30, 2022): 45–58. http://dx.doi.org/10.18196/umygrace.v2i1.412.
Повний текст джерелаFerguson, Brian. "Fraud and misconduct in medical research Summary of the report of the Royal College of Physicians." Psychiatric Bulletin 16, no. 10 (October 1992): 628–29. http://dx.doi.org/10.1192/pb.16.10.628.
Повний текст джерелаBrondz, Ilia. "Analytical Methods in Quality Control of Scientific Publications Part IV: Fraud Ordered by the Pharmaceutical Industry." International Journal of Analytical Mass Spectrometry and Chromatography 02, no. 04 (2014): 103–12. http://dx.doi.org/10.4236/ijamsc.2014.24009.
Повний текст джерелаShah, Udayan K., Douglas R. Johnston, Gina Maisto Smith, Barbara E. Ziv, and James S. Reilly. "Article Commentary: Penalties for health care fraud and abuse: January 2007-March 2008." Otolaryngology–Head and Neck Surgery 140, no. 5 (May 2009): 625–28. http://dx.doi.org/10.1016/j.otohns.2008.12.032.
Повний текст джерела